This article focuses upon environmental cases. Litigation concerning

pharmaceuticals and medical devices may raise different issues because of the role of the FDA. The interface of science and law is central to toxic tort

litigation. The challenge of eliciting valid and pertinent expert

opinions in toxic tort cases has led to changes in the role of the

judge and to what is admissible in court.3 Daubert v. Merrell Dow

Pharmaceuticals, Inc.4 and other cases have had a major impact

upon toxic tort litigation at a time when the science is also changing

rapidly.5 This article explores the role of the central toxicological

concept of dose in toxic tort litigation.

Source Article By Bernard D. Goldstein, M.DProfessor of Environmental and Occupational

Health and former Dean of the University of Pittsburgh Graduate School of

Public Health. The author would like to thank Russellyn Carruth of the

University of Pittsburgh School of Law for her many insightful observations on

this subject and for her contributions to this manuscript.

LOADING PDF: If there are any problems, click here to download the file.

Published In: Health Updates, Personal Injury Updates, Products Liability Updates, Toxic Torts Updates, Worker’s Compensation Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Paul Parks, Parks Medical-Legal Consulting | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »